PURE Bioscience, Inc. (OTCMKTS:PURE) Short Interest Update

PURE Bioscience, Inc. (OTCMKTS:PURE) saw a large drop in short interest in the month of August. As of August 15th, there was short interest totalling 77,300 shares, a drop of 18.7% from the July 31st total of 95,100 shares. Based on an average trading volume of 15,700 shares, the short-interest ratio is currently 4.9 days.

PURE Bioscience Trading Down 10.0 %

Shares of OTCMKTS:PURE traded down $0.01 on Friday, reaching $0.06. 12,000 shares of the company were exchanged, compared to its average volume of 28,694. The company has a 50-day moving average of $0.07 and a 200-day moving average of $0.08. The firm has a market cap of $7.05 million, a price-to-earnings ratio of -1.17 and a beta of 0.10. PURE Bioscience has a 1-year low of $0.06 and a 1-year high of $0.17.

PURE Bioscience (OTCMKTS:PURE) last announced its quarterly earnings results on Friday, June 14th. The company reported ($0.01) earnings per share for the quarter. The firm had revenue of $0.44 million during the quarter.

PURE Bioscience Company Profile

PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.